Share on Pinterest A clinical trial shows that Zepbound and Mounjaro reduced obstructive sleep apnea symptoms in people with obesity. NurPhoto/Getty Images Around 70% of people who have obstructive ...

TORONTO, ONTARIO, CANADA - 2014/04/12: Female wearing the CPAP mask for treating the sleep apnea which is a type of sleep disorder characterized by pauses in breathing or instances of shallow or ...

If you have overweight or obesity, losing 5–10% of your body weight may help reduce or resolve sleep apnea symptoms. Obstructive sleep apnea is a common condition that can cause problems with your ...

ORLANDO, Fla. — The diabetes and weight loss drug tirzepatide (Mounjaro for type 2 diabetes; Zepbound for obesity) was so effective at reducing sleep disruptions in patients with obesity and ...

Breakthroughs, discoveries, and DIY tips sent six days a week. Terms of Service and Privacy Policy. Tens of millions of people in the U.S. and hundreds of millions of ...

The weight-loss drug Zepbound (tirzepatide) now has another major benefit: on Dec. 20, it became the first drug approved by the U.S. Food and Drug Administration (FDA) to treat obstructive sleep apnea ...

The American Academy of Sleep Medicine has indicated that an estimated 26 percent of adults between the ages of 30 and 70 years have sleep apnea. (Photo: Getty) You could say that it’s difficult to ...

Sherri Gordon, CLC is a certified professional life coach, author, and journalist covering health and wellness, social issues, parenting, and mental health. She also has a certificate of completion ...

Share on Pinterest Obstructive sleep apnea symptoms may worsen on weekends, a trend researchers are calling “social apnea.” Getty Images A large study found that moderate to severe obstructive sleep ...